Measuring Emissions as Part of a Regulatory Regime. Prof. Riccardo Polosa Professor of Internal Medicine and Convenor CEN TC437/WG4

Similar documents
E-Cigarette Product Regulation and Standardisation

Contribution To Standards Development For Next Generation Products. Eduardo BEREA Alternative Ingredients ENDS 2018 London 4-5 June 2018

Contribution To Standards Development For Next Generation Products. Dr Nils ROSE

Pierre-Marie GUITTON Next Generation Nicotine Delivery London June, 2017

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1)

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

E-Vapour (EVAP) Sub-Group 2017 Report. Kitzbühel, Austria October 10, 2017

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

Smoking Behaviour Sub-Group (TSB)

Applicant Name: GD Sigelei Electroinc Tech Co., Ltd B7 Building, No.1 District, Xicheng Science and Technology Park, Hengli Town, Dongguan, China

Modelling the effects of user exposure to harmful emissions across the spectrum of nicotine delivery

ONLINE AEROSOL ANALYSIS USING FTIR: ASSESSING CARBONYL YIELDS IN E-CIGARETTE AEROSOL

in the ICH Regions Table of Content Annexes to Guideline and 3. Why is Q4B necessary? Q4B Annexes? for Human Use

Cooperation Centre for Scientific Research Relative to Tobacco. CORESTA Guide N 22

Sub-components in Nicotine cessation products?

Work plan for the joint CHMP/ CVMP Quality Working Party (QWP) for 2018

TOBACCO PRODUCT OR MEDICAL PRODUCT?

Recognized Pharmacopoeia in Registration system

Caption: The equipment required for testing Fluticasone Propionate (FP) Inhalation Powder in line with a new product-specific monograph (USP36-NF31).

Electronic Cigarettes and the Medical Society

European standard setting via CEN TC 437

COMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium

Responsible Practice in E-Vapour Products (EVP) Product Stewardship

Cigarettes Determination of tobacco specific nitrosamines in mainstream cigarette smoke Method using LC-MS/MS

FEATURES AND PERFORMANCE OF THE HPP SMOKING MACHINE. Dritan Xhillari

Reports of advisory bodies

ISO INTERNATIONAL STANDARD. Non-destructive testing Penetrant testing Part 1: General principles

General concepts in the Ph. Eur.: theory and rationale

2015 Report 05 October 2015 Jeju, South Korea

ISO Process and Standards Under Development. ISO Principles

Regulatory Support for Tobacco Products. Feeling daunted by the regulatory process for tobacco products? Don t worry Battelle can help.

General Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No.

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) DRAFT (12/08) POINTS TO CONSIDER ON STABILITY TESTING OF HOMEOPATHIC MEDICINAL PRODUCTS

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE?

Guideline for Advertising of e-cigarettes

BRITISH PHARMACOPOEIA COMMISSION EXPERT ADVISORY GROUP: MEDICINAL CHEMICALS 3 SUMMARY MINUTES

Analytical method validation. Presented by Debbie Parker 4 July, 2016

E-cigarette consumption and puffing topography data. Dr Sudhanshu Patwardhan FDA CTP Workshop, Hyattsville, Maryland. March 9, 2015.

E-Cigarettes: A Game Changer. Dr. Blake Brown Hugh C. Kiger Professor Agriculture and Resource Economics College of Agriculture & Life Sciences

Meeting the Quality Challenge for Orally Inhaled Drug Products. Review Impact of Emerging EMA/MHRA Guidelines and Standards

Rationale for Establishing Tobacco Product Regulation

DIRECTIVE 2014/40/UE AND TRANSPOSITION IN ITALY: LEGISLATIVE DECREE OF 12 JANUARY 2016, N. 6

Nicotine delivery from e-cigarettes part I: study designs for two pharmacokinetic studies.

The English experience in a European regulatory context. E-cigarette summit Washington DC 1 st May 2018 Deborah Arnott Chief Executive ASH (UK)

RISK FROM E-VAPOUR PRODUCTS FOR USERS AND BYSTANDERS

UK E-Cigarette Summit Relative risks of cancer posed by combustible and vapourising forms of nicotine delivery: Evidence from chemical exposures

The concept that not all tobacco and nicotine products

Towards a Smokefree Generation: A Tobacco Control Plan for England. Tim Baxter, Department of Health, England

E-Cigarette Aerosol Analysis Report

Guideline on quality of herbal medicinal products 2 /traditional herbal medicinal products

FDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update

This document is a preview generated by EVS

1st Annual Tobacco and Nicotine

E-Cigarette Aerosol Analysis Report

Smoking, e-cigs and reduced risk products. Dr John Schoonbee, IMS November 2017

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

E-Cigarette Aerosol Analysis Report

Guideline on quality of herbal medicinal products 1 /traditional herbal medicinal products

E-Cigarette Aerosol Analysis Report

Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re

RE: Docket No. FDA-2014-N , Electronic Cigarettes and the Public Health

CORESTA Guide N o 18

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

The Effect of Puff Profile and Volume on the Yields of E-Cigarettes

E-Cigarette Aerosol Analysis Report

2017_ST10_JinCathy.pdf. SSPT Document not peer-reviewed by CORESTA

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

Coventry Health Care of Georgia, Inc.

E-Cigarette Aerosol Analysis Report

Effect of Sugars on Selected Toxicant Yields in e-cigarettes

UPDATE ON THE GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS

E-cigarettes: Evidence, perceptions and misconceptions. Martin Dockrell, Tobacco Control Programme Lead

The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j))

DECISION. Recalling further its decision FCTC/COP5(6) to adopt further partial guidelines;

DEVELOPMENT OF A TECHNIQUE FOR THE DETERMINATION OF ph-values OF AEROSOLS GENERATED BY E-CIGARETTES

The Role of EPAG in Standards and Regulatory Guidance Development

The Latest on Vaping Among U.S. Teens

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS

EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS

Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

State Pharmacopoeia of Ukraine

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Air Quality assessment during indoor use of the Tobacco Heating System 2.2

Family Smoking Prevention and Tobacco Control Act. Comments regarding crop protection agents

Updating the Malaria Vaccine Technology Roadmap

Understanding Regulatory Global Requirements for Nasal Drug Products. Julie D. Suman, Ph.D. April 8, 2016

ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS)

Harmful and potentially harmful constituents in e-cigarettes

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) POINTS TO CONSIDER ON THE JUSTIFICATION OF HOMEOPATHIC USE

Proposed Deeming Regulations: What s the Path Forward?

Key Variables in Assessing ENDS Devices AND WHY THAT ISN T VOLTS

Next Generation Products Sandra Costigan, Marianna Gaca, ChuanLiu, Kevin McAdam, James J. Murphyand Christopher Proctor British American Tobacco 21

Guideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture

00:08 For decades our scientists have endeavoured to reduce the risks of tobacco use and continue to do so today. 00:15

Transcription:

Measuring Emissions as Part of a Regulatory Regime Prof. Riccardo Polosa Professor of Internal Medicine and Convenor CEN TC437/WG4

. (b) a list of all ingredients contained in, and emissions resulting from the use of, the product, by brand name and type, including quantities thereof; (c) toxicological data regarding the product's ingredients and emissions, including when heated, referring in particular to their effects on the health of consumers when inhaled and taking into account, inter alia, any addictive effect;

Annex notification requirements Emissions: it is required that the methods for testing be described, but there is no information on which emissions they want data.

Room for interpretation.

Room for interpretation.

Room for interpretation.

CEN/TC 437 Setting quality and safety standards CEN/TC 437 E-cigarettes and e-liquids agrees to launch a 3 month ballot for the creation of: WG 4 "Requirements and test methods for emissions" to work on: Testing conditions, equipment and environment Reference products Measurements/quantification/qualification of emissions Consistent delivery of nicotine

CEN/TC 437/WG 4 Requirements and test methods for emissions Workplan priorities: CEN/TC 437 E-cigarettes and e-liquids agrees to launch a 3 month ballot for the creation of: WG 4 "Requirements and test methods for emissions" to work on: Testing conditions, equipment and environment (e.g. puffing parameters, aerosol generation and collection, laboratory environmental conditions) Liaison with ISO/TC 126/SC 3/WG 2 CORESTA CRM 81 AFNOR XP D 90-300-3 Testing conditions, equipment and environment Reference products Measurements/quantification/qualification of emissions Consistent delivery of nicotine

CEN/TC 437/WG 4 Requirements and test methods for emissions Workplan priorities: Reference products CEN/TC 437 E-cigarettes and e-liquids agrees to launch a 3 month ballot for the creation of: WG 4 "Requirements and test methods for emissions" to work on: Testing conditions, equipment and environment Reference products Measurements/quantification/qualification of emissions Reference liquid (e.g. ingredients characteristics, storage conditions) BSI/PAS 54115:2015 AFNOR XP D 90-300-2 AEMSA e-liquid manufacturing standards Specific reference liquids for analytical methods validation Reference device (e.g. technical parameters, design) BSI/PAS 54115:2015 AFNOR XP D 90-300-3 US document Consistent delivery of nicotine

CEN/TC 437/WG 4 Requirements and test methods for emissions CEN/TC 437 E-cigarettes and e-liquids agrees to launch a 3 month ballot for the creation of: WG 4 "Requirements and test methods for emissions" to work on: Testing conditions, equipment and environment Reference products Measurements/quantification/qualification of emissions Consistent delivery of nicotine Workplan priorities: Measurements/quantification/q ualification of emissions Constituent to be measured in the emissions: Nicotine Carbonyls Metals TPD draft data dictionary for e-cig MHRA document BSI/PAS 54115:2015 AFNOR XP D 90-300-3 FDA guidance

CEN/TC 437/WG 4 Requirements and test methods for emissions CEN/TC 437 E-cigarettes and e-liquids agrees to launch a 3 month ballot for the creation of: WG 4 "Requirements and test methods for emissions" to work on: Testing conditions, equipment and environment Reference products Measurements/quantification/qualification of emissions Consistent delivery of nicotine Workplan priorities: Measurements/quantification/q ualification of emissions Analytical methods for constituents to be measured in the emissions: availability of analytical methods applicability of analytical methods ICH Guidance Q2 British Pharmacopoeia (BP) European Pharmacopoeia (Ph Eur) US Pharmacopeia-National Formulary Japonese Pharmacopoeia (JP) development or modification of test methods, if required expression of the results validation

CEN/TC 437/WG 4 Requirements and test methods for emissions Workplan priorities: CEN/TC 437 E-cigarettes and e-liquids agrees to launch a 3 month ballot for the creation of: WG 4 "Requirements and test methods for emissions" to work on: Testing conditions, equipment and environment Reference products Measurements/quantification/qualification of emissions Consistent delivery of nicotine Consistent delivery of nicotine (e.g. parameters and definitions) CHMP guidance: Pharmaceutical quality of inhalation and nasal products ICH Guidance Q2 (R1): Validation of analytical procedures: text and methodology EU pharmacopoeia - Ph Eur monograph 2.9.40 (Uniformity of Dosage Units) AFNOR XP D 90-300-3

CEN/TC 437/WG 4 Requirements and test methods for emissions Challenges & Concerns Need for substantial coordination Growing complexity (likely WI proliferation) Loss of human resources (increasing no-show) Can we meet the deadline?